Ph. D. students
Hongjun Chang (Biology) | |
hjchang23@kaist.ac.kr | |
Seong-hoon Jang (Bio and brain Engineering) | |
jangdeath@kaist.ac.kr | |
Hoon-min Kim (Physics & Bio and Brain Engineering) | |
hunmin007@kaist.ac.kr | |
Juhee Kim (Life Sciences) | |
juheekim@kaist.ac.kr | |
Hyunjin Kim (Nursing & Biomedical Science and Engineering) | |
hyunjin0430@kaist.ac.kr | |
Corbin Hopper (Bio & Brain Engineering) | |
chopper@kaist.ac.kr | |
Woojeong Lee (Biological Sciences) | |
frship35@kaist.ac.kr Research Interests
| |
Seoyoon Jeong (Physics & Life Science) | |
syjeong@kaist.ac.kr
| |
Jeonghwan Min (Life Science and Biotechnology) | |
m_jeonghwan@kaist.ac.kr
Systems biology seeks to simulate real cellular dynamics by focusing on these pathway interactions. With the systems biology approach, I seek to create a platform for discovering novel drug targets and drug combinations for a disease. My ultimate goal is to use this platform to cure long-unresolved diseases such as cancer and aging.
| |
Yujin Nam (Computer Science) | |
yujin.nam@kaist.ac.kr Research Interests We have long believed aging is inevitable, but it may not. All living organisms are constructed based on what is written on the genome, and grow old as a ball rolling along a slope. I believe controlling this slope, which is genomic landscape, can cure aging. I'm exploring it with computing, network control theory, and cell experiments.
| |
Hyunsoo Yeo (Bio and Brain Engineering) | |
nky0309@kaist.ac.kr | |
Hojun Lee (Biological Sciences) | |
freefromseoul@kaist.ac.kr | |
Yoonsu Na (Biology & Convergence Software) | |
ysna99@kaist.ac.kr
As human health and cancer treatment is becoming one of the most important issue among the world, I think Systems Biology is a key breakthrough to deal with these issues. By modeling and analyzing various biological networks, we might be able to find novel target which is engaged in reversion of tumor to normal state. With concepts of Boolean network and control theory, I think it is not impossible to make a therapeutic strategies for unconquered cancer types. Keywords | |
Lisa Chuttoo (Bio-Medical Engineering) | |
lisa.chuttoo@kaist.ac.kr Research Interest The study of the processes of carcinogenesis, especially the onset of cancer and the critical transition to malignancy, drives my work. By integrating the different theories of cancer, the goal is to enhance the relevance of these frameworks for translational medicine and maximize their clinical impact on patient care.
Cancer biology, Cancer theories, Translational oncology | |
M. S. students
Myoungbo Kang (Biotechnology & Statistic) | |
mbkang@kaist.ac.kr | |
Junseo Seo (Systems Biomedical Science) | |
juneseo99@kaist.ac.kr | |
Minkyung Kim (Life Science & Biological Information SW) | |
minkyung32@kaist.ac.kr | |
Rafsan Rahman Raayan (Bio & Brain Engineering, Electrical Engineering) | |
rafsan.raayan@kaist.ac.kr | |
Seoyoung Yoon (Biosystems and Biomedical Sciences) | |
seoyoung09@kaist.ac.kr Cancer therapy, Systems biology | |
Nabi Gali (Life Science and Biotechnology) | |
nabigali5@kaist.ac.kr Cancer biology, Molecular biology, Systems biology | |
Hee Kyung Jo (Biochemistry) | |
joheek@kaist.ac.kr | |
Arundhati Sanjith (Nanosciences and Molecular Medicine) | |
arundhatisanjith@kaist.ac.kr Research Interests My research interests focus on cancer biology and the idea of cancer reversion driven by the need to develop alternative therapeutic strategies that can overcome the limitations, patient burden, and risk of recurrence associated with conventional treatments. I am particularly interested in understanding cancer as a complex, dynamic system. I’m especially interested in viewing cancer as a dynamic system. I aim to pursue integrative approaches that bridges computational and experimental biology to better understand and eventually modulate complex cancer processes. Keywords Cancer biology, Computational–experimental integration, Systems-level therapeutic modulation | |
Natasya Paulita (Biological Science) | |
natasyap@kaist.ac.kr Research Interests My research interest lies in uncovering the molecular regulatory networks that govern cancer cell fate decisions, particularly apoptosis and drug resistance. I am especially interested in understanding how key master regulators control signaling pathways and transcriptional programs in treatment-resistant cancers. By perturbing selected candidate regulators, I aim to examine how these interventions reshape intracellular signaling dynamics and alter gene expression patterns that enable cancer cells to survive therapy. Through reconstructing network-level mechanisms, I hope to clarify how tumor heterogeneity arises and how adaptive resistance develops over time. Molecular regulatory networks, Cell fate decisions, Tumor heterogeneity and adaptive resistance | |









